Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC vs FFP in Intracranial Hemorrhage
NCT02429453Withdrawn
- Sponsor
- University of Utah
- Start
- Apr 2015
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of coagulation factor X human in intracranial hemorrhage (ICH) (2 arms), sponsored by University of Utah. Primary endpoint: Rapid reversal of warfarin as measured by international normalized ratio (INR) at 30 minutes. Planned start Apr 2015; status: withdrawn.
02
Drugs
coagulation factor X human
03
Conditions
intracranial hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02429453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429453.